Montreal—One of the first studies of its kind has found that serial fecal microbiota transplants in children with active ulcerative colitis led to greater improvements in serum and stool inflammatory markers as well as clinical response than did placebo.
The researchers found that these improvements persisted for more than six months after the final treatment.
“The families of children with ulcerative colitis are usually given the option of starting on immunosuppressive treatment,